RecruitingNCT07511413

GALENOS 1 in Head and Neck, Lung, and Rectal Cancer Patients

An Observational Study on Longitudinal Nutritional Status and Body Composition Changes in Head and Neck Cancer, Lung Cancer and Rectal Cancer Patients During Antineoplastic Treatments

Sponsor

Fondazione del Piemonte per l'Oncologia

Enrollment

110 participants

Start Date

Sep 23, 2024

Study Type

OBSERVATIONAL

Conditions

Lung Cancer Head and Neck Squamous Cell Carcinoma Locally Advanced Rectal Cancer

Summary

GALENOS 1 is a prospective observational study designed to explore longitudinal changes in nutritional status and body composition in patients with head and neck squamous cell carcinoma, locally advanced rectal cancer, and lung cancer undergoing standard antineoplastic treatments. The study is the preparatory observational component of the FOR-GALE PREVENTION project, which aims to support the future development of a galenic immunonutrition dietary supplement intended to reduce adverse events and improve treatment compliance

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with head and neck squamous cell carcinoma, locally advanced rectal cancer, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.